A Study of Carbamazepine (CBZ) and MK-8527 in Healthy Adult Participants (MK-8527-012)
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
A Study of Islatravir (ISL) and Ulonivirine (ULO) Once Weekly (QW) in Virologically Suppressed Adults With Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8591B-060)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
- Status
- RECRUITING
- Phase
- PHASE2
Can Stories Encourage the Elderly to Vaccinate? Combining Viewer-tailored Personal Narrative Videos With Informational Videos to Improve Vaccine Uptake Among Older Adults
- Status
- RECRUITING
- Phase
- NA
A Clinical Study to Evaluate Enlicitide (MK-0616) Formulations in Healthy Adult Participants (MK-0616-035)
- Status
- COMPLETED
- Phase
- PHASE1
Artificial Intelligence Diagnostic Decision Support to Reduce Antimicrobial Prescriptions in Young Children With Colds
- Status
- RECRUITING
- Phase
- NA
A Study of Raludotatug Deruxtecan (R-DXd) in People With Gastrointestinal Cancers (MK-5909-005)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Evaluate Opevesostat (MK-5684) in Male Participants With Moderate Hepatic Impairment (MK-5684-009)
- Status
- COMPLETED
- Phase
- PHASE1
Tailored Electronic Intervention to Improve Therapy in a Diverse Cohort of Patients With Heart Failure
- Status
- COMPLETED
- Phase
- NA
Single-Ascending Dose Study of MK-2060 in Healthy Chinese Male Adult Participants (MK-2060-009)
- Status
- COMPLETED
- Phase
- PHASE1
A Clinical Study of MK-7962 in Healthy Chinese Participants (MK-7962-021)
- Status
- COMPLETED
- Phase
- PHASE1
A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
- Status
- RECRUITING
- Phase
- PHASE3
A Clinical Study of Efinopegdutide (MK-6024) in Healthy Chinese Volunteers (MK-6024-011)
- Status
- COMPLETED
- Phase
- PHASE1
Activity Tracking Study in Healthy Volunteers (MK-0000-419)
- Status
- COMPLETED
- Phase
- PHASE1
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
- Status
- RECRUITING
- Phase
- PHASE2
Single Dose Study of Tulisokibart (MK-7240) in Healthy Chinese Participants (MK-7240-002)
- Status
- COMPLETED
- Phase
- PHASE1
A Clinical Study of Boserolimab (MK-5890) With Pembrolizumab and Chemotherapy in People With Early Triple-Negative Breast Cancer (MK-5890-003)
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of MK-8527 in Healthy Adult Participants (MK-8527-013)
- Status
- COMPLETED
- Phase
- PHASE1